Artiva Biotherapeutics Inc. (ARTV) Stock Price, Quote & News

Company Profile

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associa...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 267 4467

Website: www.artivabio.com

Address:

5505 Morehouse Drive, Suite 100, San Diego, United States

Zackpedia Dec. 17 at 10:55 PM

$ARTV You could’ve sold when I alerted and bought back at 4.2 if you wanted, hit Follow and subscribe to get my alerts on time and make money

1 · Reply

StockVolcano Dec. 17 at 9:33 PM

$AMCI $ARTV $BEAT $SMX $SUGP ☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️

0 · Reply

StockVolcano Dec. 17 at 4:48 PM

$AMCI $ARTV $BEAT $SMX $SUGP ⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️

0 · Reply

p983 Dec. 17 at 3:05 PM

$ARTV Inside 4.17

0 · Reply

StockVolcano Dec. 17 at 4:53 AM

$AMCI $ARTV $BEAT $SMX $SUGP Very interesting!!!!

0 · Reply

SWEEN24 Dec. 16 at 10:29 PM

$ARTV oh no. Now im blocked from reading nonsensical babble by love to learn. How will i ever move on.

0 · Reply

GSP Dec. 16 at 10:19 PM

$ARTV $VOR $NXDR $QCLS $CLYM

0 · Reply

lenten Dec. 16 at 9:51 PM

$ARTV $VOR $NXDR $QCLS $CLYM

0 · Reply

SWEEN24 Dec. 16 at 9:23 PM

$ARTV how this guy has 1k followers, ill never know. Never understand anything he posts.

2 · Reply

Love_To_Learn Dec. 16 at 7:37 PM

$ARTV me off 4.47*

0 · Reply

Artiva Biotherapeutics Announces Positive Initial Safety and Translational Data Supporting Deep B-Cell Depletion with AlloNK® in Autoimmune Disease

Nov 12, 2025, 7:00 AM EST - 5 weeks ago

Artiva Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Nov 3, 2025, 4:05 PM EST - 6 weeks ago

Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®

Oct 30, 2025, 4:17 PM EDT - 6 weeks ago

Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November

$Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update$

Oct 16, 2025, 4:05 PM EDT - 2 months ago

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

Aug 25, 2025, 4:05 PM EDT - 4 months ago

Artiva Biotherapeutics to Participate in the Cantor Global Healthcare Conference 2025

Aug 6, 2025, 4:05 PM EDT - 4 months ago

Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights

May 28, 2025, 4:05 PM EDT - 7 months ago

Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference

May 13, 2025, 4:05 PM EDT - 7 months ago

Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

May 8, 2025, 8:00 AM EDT - 7 months ago

Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights

Apr 28, 2025, 4:35 PM EDT - 8 months ago

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 8, 2025, 4:05 PM EDT - 9 months ago

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Mar 31, 2025, 4:05 PM EDT - 9 months ago

Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 24, 2025, 4:05 PM EDT - 9 months ago

Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Feb 20, 2025, 4:05 PM EST - 10 months ago

Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

Jan 29, 2025, 4:05 PM EST - 11 months ago

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

Nov 12, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Nov 11, 2024, 4:05 PM EST - 1 year ago

Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference

Oct 22, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

Sep 10, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 13, 2024, 2:14 PM EDT - 1 year ago

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Jul 22, 2024, 3:55 PM EDT - 1 year ago

Artiva: Natural Killer Cell Biotech With 1st Half Of 2025 Lupus Treatment Data

Jul 20, 2024, 4:50 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week

ACTU ARDT CON LINE OS QMMM TWFG

Jul 18, 2024, 7:08 PM EDT - 1 year ago

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Zackpedia Dec. 17 at 10:55 PM

$ARTV You could’ve sold when I alerted and bought back at 4.2 if you wanted, hit Follow and subscribe to get my alerts on time and make money

1 · Reply

StockVolcano Dec. 17 at 9:33 PM

$AMCI $ARTV $BEAT $SMX $SUGP ☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️☀️

0 · Reply

StockVolcano Dec. 17 at 4:48 PM

$AMCI $ARTV $BEAT $SMX $SUGP ⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️⚡️

0 · Reply

p983 Dec. 17 at 3:05 PM

$ARTV Inside 4.17

0 · Reply

StockVolcano Dec. 17 at 4:53 AM

$AMCI $ARTV $BEAT $SMX $SUGP Very interesting!!!!

0 · Reply

SWEEN24 Dec. 16 at 10:29 PM

$ARTV oh no. Now im blocked from reading nonsensical babble by love to learn. How will i ever move on.

0 · Reply

GSP Dec. 16 at 10:19 PM

$ARTV $VOR $NXDR $QCLS $CLYM

0 · Reply

lenten Dec. 16 at 9:51 PM

$ARTV $VOR $NXDR $QCLS $CLYM

0 · Reply

SWEEN24 Dec. 16 at 9:23 PM

$ARTV how this guy has 1k followers, ill never know. Never understand anything he posts.

2 · Reply

Love_To_Learn Dec. 16 at 7:37 PM

$ARTV me off 4.47*

0 · Reply

Love_To_Learn Dec. 16 at 7:37 PM

$ARTV acquired 8.7 million shares off the books now

0 · Reply

brandon_thomas88 Dec. 16 at 7:21 PM

$ARTV thin biotech tape flatlining, quiet accumulation into a data window gives strong asymmetry on any readout

0 · Reply

KatalinaV Dec. 16 at 6:32 PM

$ARTV thin biotech drifting sideways, quiet accumulation near support gives solid asymmetry into the next catalyst

0 · Reply

Onebasecapital Dec. 16 at 6:30 PM

$ARTV down -30% on less than 3 million shares after near +100% run up yesterday on +40 million shares. I'd be 'fearful' if price was down -30% on 10mil shrs or more. 'Healthy' pullback today.

1 · Reply

elmono Dec. 16 at 6:01 PM

$ARTV sub 4 and we see accelerated selling. Most buying done between 4-5….so baggies are being created as we speak. Probably dump below 3

0 · Reply

Zackpedia Dec. 16 at 5:05 PM

$ARTV Down to 4.6 now

2 · Reply

u_R_a_bagholder Dec. 16 at 4:46 PM

$ARTV who got bagged up in the blatant pump n dump yesterday ?

0 · Reply

IBOTTheDipAndTheDipWon Dec. 16 at 4:30 PM

$ARTV Now that I'm no longer short the expected dump comes.

0 · Reply

doomerboomer Dec. 16 at 4:02 PM

$ARTV Next time dumb analysts say something, fart in their face and take a dump 🤣. If all the analysts projections were mostly right, we would all be billionaires 😂😂. Shitstoks are shit for a reason.

1 · Reply

Gurujoe Dec. 16 at 3:50 PM

$ARTV market makers pushing retail out in early trading. Added more at under $4.90.. Good luck longs.

0 · Reply

Zackpedia Dec. 16 at 3:42 PM

$ARTV You could’ve sold when I alerted and bought back at 4.76 if you wanted.

1 · Reply

doomerboomer Dec. 16 at 3:38 PM

$ARTV Yesterday I posted this lol

0 · Reply

Market Cap	N/A
Revenue (ttm)	33.49M
Net Income (ttm)	-27.70M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	342,500
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A